Can-Fite BioPharma Ltd. Cash Equivalents, at Carrying Value
Can-Fite BioPharma Ltd. (CANF) had Cash Equivalents, at Carrying Value of $8.54 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-26
- 2025-12-31: Cash Equivalents, at Carrying Value $8.54M.
- 2025-06-30: Cash Equivalents, at Carrying Value $6.45M.
- 2024-06-30: Cash Equivalents, at Carrying Value $4.72M.
- 2023-06-30: Cash Equivalents, at Carrying Value $3.46M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $8.54M 20-F · filed 2026-03-26 |
| 2025-06-30 | $6.45M 6-K · filed 2025-08-28 |
| 2024-06-30 | $4.72M 6-K · filed 2024-08-29 |
| 2023-06-30 | $3.46M 6-K · filed 2023-08-31 |
| 2022-12-31 | $2.98M 6-K · filed 2023-08-31 |
| 2022-06-30 | $1.71M 6-K · filed 2022-08-25 |
| 2021-12-31 | $4.39M 6-K · filed 2022-08-25 |
| 2021-06-30 | $1.02M 6-K · filed 2021-08-26 |
| 2020-12-31 | $8.27M 6-K · filed 2021-08-26 |